DZ2320A1 - Antagonistes de récepteurs de vitronectine. - Google Patents

Antagonistes de récepteurs de vitronectine.

Info

Publication number: DZ2320A1
Authority: DZ; Algeria
Prior art keywords: receptor antagonists; vitronectin receptor; vitronectin; antagonists; receptor
Prior art date: 1996-10-02

Application number

DZ970170A

Other languages

English (en)

Original Assignee

Smithkline Beecham Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-10-02

Filing date

1997-09-29

Publication date

2002-12-28

1997-09-29 Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp

2002-12-28 Application granted granted Critical

2002-12-28 Publication of DZ2320A1 publication Critical patent/DZ2320A1/fr

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Inorganic Chemistry (AREA)
Vascular Medicine (AREA)
Pain & Pain Management (AREA)
Oncology (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

DZ970170A 1996-10-02 1997-09-29 Antagonistes de récepteurs de vitronectine. DZ2320A1 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US2732096P	1996-10-02	1996-10-02
US4377697P	1997-04-11	1997-04-11

Publications (1)

Publication Number	Publication Date
DZ2320A1 true DZ2320A1 (fr)	2002-12-28

Family

ID=26702318

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DZ970170A DZ2320A1 (fr)	1996-10-02	1997-09-29	Antagonistes de récepteurs de vitronectine.

Country Status (36)

Country	Link
EP (1)	EP0957917B1 (fr)
JP (2)	JP4491072B2 (fr)
KR (1)	KR100589578B1 (fr)
CN (1)	CN1114403C (fr)
AP (1)	AP1463A (fr)
AR (1)	AR008878A1 (fr)
AT (1)	ATE312089T1 (fr)
AU (1)	AU733417B2 (fr)
BG (1)	BG64581B1 (fr)
BR (1)	BR9712248B1 (fr)
CA (1)	CA2267224C (fr)
CO (1)	CO4900046A1 (fr)
CY (1)	CY2576B1 (fr)
CZ (1)	CZ299076B6 (fr)
DE (1)	DE69734833T2 (fr)
DK (1)	DK0957917T3 (fr)
DZ (1)	DZ2320A1 (fr)
EA (1)	EA002419B1 (fr)
ES (1)	ES2252775T3 (fr)
HU (1)	HU229221B1 (fr)
ID (1)	ID19623A (fr)
IL (1)	IL129243A (fr)
MA (1)	MA24361A1 (fr)
MY (1)	MY137606A (fr)
NO (1)	NO320194B1 (fr)
NZ (1)	NZ334953A (fr)
PE (1)	PE10499A1 (fr)
PL (1)	PL190859B1 (fr)
RO (1)	RO119881B1 (fr)
SA (1)	SA98180936B1 (fr)
SK (1)	SK285029B6 (fr)
TR (1)	TR199900737T2 (fr)
TW (1)	TW487702B (fr)
UA (1)	UA60311C2 (fr)
UY (2)	UY24735A1 (fr)
WO (1)	WO1998014192A1 (fr)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2000066106A2 (fr) *	1999-04-30	2000-11-09	The Regents Of The University Of Michigan	Applications therapeutiques de benzodiazepines pro-apoptotiques
UA60311C2 (uk) *	1996-10-02	2003-10-15	Смітклайн Бічам Корпорейшн	Антагоністи рецептора вітронектину, спосіб одержання цих сполук та фармацевтична композиція
TW527355B (en)	1997-07-02	2003-04-11	Bristol Myers Squibb Co	Inhibitors of farnesyl protein transferase
PL339413A1 (en) *	1997-09-24	2000-12-18	Smithkline Beecham Corp	Antagonistic vitronectin receptor
EP1023073A1 (fr) *	1997-09-24	2000-08-02	Smithkline Beecham Corporation	Antagoniste du recepteur de la vitronectine
US6372719B1 (en) *	1998-03-04	2002-04-16	Jay Cunningham	ανβ3 integrin antagonists in combination with chemotherapeutic agents
DE19842415A1 (de) *	1998-09-16	2000-03-23	Merck Patent Gmbh	Pharmazeutische Zubereitung
JP2002533404A (ja) *	1998-12-23	2002-10-08	ジー・ディー・サール・アンド・カンパニー	新生物形成の治療における組合わせ療法としてインテグリン拮抗剤及び放射線治療を使用する方法
WO2000046215A1 (fr) *	1999-02-03	2000-08-10	Merck & Co., Inc.	Derives de la benzazepine utilises comme antagonistes du recepteur alpha-v de l'integrine
EP1208101A4 (fr) *	1999-08-06	2003-03-19	Smithkline Beecham Corp	Antagonistes du recepteur de la vitronectine utiles pour le traitement des accidents vasculaires cerebraux
US6514964B1 (en)	1999-09-27	2003-02-04	Amgen Inc.	Fused cycloheptane and fused azacycloheptane compounds and their methods of use
DE10028575A1 (de)	2000-06-14	2002-03-14	Basf Ag	Integrinliganden
DE10027514A1 (de) *	2000-06-06	2002-01-03	Basf Ag	Liganden von Integrinrezeptoren
FR2806082B1 (fr) *	2000-03-07	2002-05-17	Adir	Nouveaux composes bicycliques antagonistes des recepteurs de la vitronectine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US6855722B2 (en)	2001-01-29	2005-02-15	Dimensional Pharmaceuticals, Inc.	Substituted indoles and their use as integrin antagonists
PL364526A1 (en) *	2001-04-10	2004-12-13	Smithkline Beecham Corporation	Method of inhibiting adhesion formation
SE0101386D0 (sv)	2001-04-20	2001-04-20	Astrazeneca Ab	New compounds
US7109191B2 (en)	2001-05-03	2006-09-19	Merck & Co., Inc.	Benzazepinone alpha vintegrin receptor antagonists
KR20040058229A (ko)	2001-10-22	2004-07-03	더 스크립스 리서치 인스티튜트	항체 표적화 화합물
GB0215867D0 (en) *	2002-07-09	2002-08-14	Glaxosmithkline Spa	Novel method and compounds
JP2006522139A (ja) *	2003-04-04	2006-09-28	スミスクライン・ビーチャム・コーポレイション	ベンズアゼピンの製造方法およびその中間体
HRP20130782T1 (en)	2004-04-02	2013-09-30	The Regents Of The University Of California, Office Of Technology Transfer	Methods and compositions for treating and preventing disease associated with alpha v beta 5 integrin
AU2012216372B2 (en) *	2004-04-02	2015-01-22	The Regents Of The University Of California	Methods and compositions for treating and preventing disease associated with alphaVbeta5 integrin
UA87854C2 (en)	2004-06-07	2009-08-25	Мерк Энд Ко., Инк.	N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators
AR052823A1 (es) *	2004-12-21	2007-04-04	Smithkline Beecham Corp	Uso de un antagonista del receptor de vitronectina para l a preparacion de una formulacion farmaceutica util para inhibir el exceso de formacion de cicatrices en la piel de a un mamifero y dicha formulacion
US20080293691A1 (en) *	2005-11-29	2008-11-27	Smithkline Beecham Corporation	Treatment Method
EP2217238B1 (fr)	2007-11-08	2014-03-12	The General Hospital Corporation	Procédés et compositions pour le traitement de maladies protéinuriques
ES2428896T3 (es)	2007-11-16	2013-11-12	Ube Industries, Ltd.	Compuesto de benzacepinona
WO2009111679A2 (fr) *	2008-03-06	2009-09-11	Smithkline Beecham Corporation	Procédé
EP2395992A2 (fr)	2009-02-10	2011-12-21	The Scripps Research Institute	Vaccination programmée chimiquement
JPWO2010113958A1 (ja)	2009-03-30	2012-10-11	宇部興産株式会社	眼の疾患の治療又は予防のための医薬組成物
JP5572996B2 (ja) *	2009-05-15	2014-08-20	宇部興産株式会社	ベンズアゼピノン化合物を有効成分として含有する医薬
EP2456460A4 (fr)	2009-07-24	2013-02-20	Univ California	Procédés et compositions destinés à traiter et à prévenir des maladies associées à l'intégrine v 5
US9126978B2 (en)	2009-11-17	2015-09-08	The Regents Of The University Of Michigan	1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
EP2325194A1 (fr) *	2009-11-24	2011-05-25	Glycotope GmbH	Processus de purification de glycoprotéines
JP6649902B2 (ja)	2014-05-30	2020-02-19	ファイザー・インク	選択的アンドロゲン受容体モジュレーターとしてのカルボニトリル誘導体
BR112022021228A2 (pt) *	2020-04-26	2022-12-06	Jiangsu Nhwa Pharmaceutical Co Ltd	Derivado da 1,5-di-hidro-2,4-benzodiazepin-3-ona e aplicação do mesmo
WO2023275715A1 (fr)	2021-06-30	2023-01-05	Pfizer Inc.	Métabolites de modulateurs sélectifs du récepteur des androgènes

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE236882T1 (de) *	1992-12-21	2003-04-15	Smithkline Beecham Corp	Bicyklische fibrinogen antagoniste
BR9508178A (pt) *	1994-06-29	1997-11-18	Smithkline Beecham Corp	Antagonistas de receptor de vitronectina
JPH10504807A (ja) *	1994-06-29	1998-05-12	スミスクライン・ビーチャム・コーポレイション	ビトロネクチン受容体拮抗剤
JPH10504825A (ja) *	1994-08-22	1998-05-12	スミスクライン・ビーチャム・コーポレイション	二環式化合物
WO1996026190A1 (fr) *	1995-02-22	1996-08-29	Smithkline Beecham Corporation	Antagonistes des recepteurs a l'integrine
UA60311C2 (uk) *	1996-10-02	2003-10-15	Смітклайн Бічам Корпорейшн	Антагоністи рецептора вітронектину, спосіб одержання цих сполук та фармацевтична композиція

1997
- 1997-01-10 UA UA99031739A patent/UA60311C2/uk unknown
- 1997-09-29 DZ DZ970170A patent/DZ2320A1/fr active
- 1997-09-30 MA MA24817A patent/MA24361A1/fr unknown
- 1997-09-30 MY MYPI97004552A patent/MY137606A/en unknown
- 1997-10-01 NZ NZ334953A patent/NZ334953A/xx not_active IP Right Cessation
- 1997-10-01 EA EA199900356A patent/EA002419B1/ru not_active IP Right Cessation
- 1997-10-01 IL IL12924397A patent/IL129243A/en not_active IP Right Cessation
- 1997-10-01 JP JP51694298A patent/JP4491072B2/ja not_active Expired - Fee Related
- 1997-10-01 EP EP97909979A patent/EP0957917B1/fr not_active Expired - Lifetime
- 1997-10-01 AT AT97909979T patent/ATE312089T1/de active
- 1997-10-01 PL PL332674A patent/PL190859B1/pl unknown
- 1997-10-01 ID IDP973335A patent/ID19623A/id unknown
- 1997-10-01 HU HU9903769A patent/HU229221B1/hu not_active IP Right Cessation
- 1997-10-01 DE DE69734833T patent/DE69734833T2/de not_active Expired - Lifetime
- 1997-10-01 TR TR1999/00737T patent/TR199900737T2/xx unknown
- 1997-10-01 CZ CZ0113299A patent/CZ299076B6/cs not_active IP Right Cessation
- 1997-10-01 AP APAP/P/1999/001493A patent/AP1463A/en active
- 1997-10-01 CO CO97057225A patent/CO4900046A1/es unknown
- 1997-10-01 PE PE1997000876A patent/PE10499A1/es not_active Application Discontinuation
- 1997-10-01 DK DK97909979T patent/DK0957917T3/da active
- 1997-10-01 CN CN97180168A patent/CN1114403C/zh not_active Expired - Fee Related
- 1997-10-01 WO PCT/US1997/018001 patent/WO1998014192A1/fr not_active Ceased
- 1997-10-01 CA CA002267224A patent/CA2267224C/fr not_active Expired - Fee Related
- 1997-10-01 SK SK425-99A patent/SK285029B6/sk not_active IP Right Cessation
- 1997-10-01 UY UY24735A patent/UY24735A1/es not_active IP Right Cessation
- 1997-10-01 RO RO99-00353A patent/RO119881B1/ro unknown
- 1997-10-01 BR BRPI9712248-3A patent/BR9712248B1/pt not_active IP Right Cessation
- 1997-10-01 AU AU47462/97A patent/AU733417B2/en not_active Ceased
- 1997-10-01 KR KR1019997002811A patent/KR100589578B1/ko not_active Expired - Fee Related
- 1997-10-01 ES ES97909979T patent/ES2252775T3/es not_active Expired - Lifetime
- 1997-10-02 AR ARP970104549A patent/AR008878A1/es active IP Right Grant
1998
- 1998-02-10 TW TW086114545A patent/TW487702B/zh not_active IP Right Cessation
- 1998-03-01 SA SA98180936A patent/SA98180936B1/ar unknown
- 1998-03-25 UY UY24935A patent/UY24935A1/es not_active IP Right Cessation
1999
- 1999-03-31 BG BG103299A patent/BG64581B1/bg unknown
- 1999-03-31 NO NO19991590A patent/NO320194B1/no not_active IP Right Cessation
2007
- 2007-05-18 CY CY0700010A patent/CY2576B1/xx unknown
2009
- 2009-10-09 JP JP2009235447A patent/JP2010006838A/ja active Pending

Also Published As

Publication number	Publication date
NO991590L (no)	1999-05-31
AP1463A (en)	2005-09-10
NO320194B1 (no)	2005-11-14
EP0957917A4 (fr)	2002-05-15
AP9901493A0 (en)	1999-03-31
CN1238689A (zh)	1999-12-15
BR9712248B1 (pt)	2010-06-29
TW487702B (en)	2002-05-21
KR100589578B1 (ko)	2006-06-15
HUP9903769A3 (en)	2000-07-28
CA2267224C (fr)	2007-03-13
MY137606A (en)	2009-02-27
UY24735A1 (es)	1998-03-30
PE10499A1 (es)	1999-03-27
KR20000048816A (ko)	2000-07-25
DE69734833D1 (de)	2006-01-12
IL129243A0 (en)	2000-02-17
ID19623A (id)	1998-07-23
HUP9903769A2 (hu)	2000-03-28
JP2001501936A (ja)	2001-02-13
CZ299076B6 (cs)	2008-04-16
DE69734833T2 (de)	2006-07-13
WO1998014192A1 (fr)	1998-04-09
PL332674A1 (en)	1999-09-27
EA002419B1 (ru)	2002-04-25
PL190859B1 (pl)	2006-02-28
NZ334953A (en)	2000-01-28
SA98180936B1 (ar)	2006-05-30
BG103299A (en)	2000-01-31
EP0957917B1 (fr)	2005-12-07
EA199900356A1 (ru)	2000-02-28
BG64581B1 (bg)	2005-08-31
NO991590D0 (no)	1999-03-31
CN1114403C (zh)	2003-07-16
ATE312089T1 (de)	2005-12-15
CY2576B1 (en)	2008-07-02
SK285029B6 (sk)	2006-04-06
CZ113299A3 (cs)	2000-03-15
CA2267224A1 (fr)	1998-04-09
JP4491072B2 (ja)	2010-06-30
MA24361A1 (fr)	1998-07-01
HK1023730A1 (en)	2000-09-22
AR008878A1 (es)	2000-02-23
HU229221B1 (en)	2013-09-30
IL129243A (en)	2004-07-25
AU733417B2 (en)	2001-05-17
BR9712248A (pt)	1999-08-24
AU4746297A (en)	1998-04-24
RO119881B1 (ro)	2005-05-30
UY24935A1 (es)	2001-07-31
JP2010006838A (ja)	2010-01-14
TR199900737T2 (xx)	1999-07-21
CO4900046A1 (es)	2000-03-27
UA60311C2 (uk)	2003-10-15
DK0957917T3 (da)	2006-04-18
ES2252775T3 (es)	2006-05-16
SK42599A3 (en)	1999-12-10
EP0957917A1 (fr)	1999-11-24

Publication	Publication Date	Title
DZ2320A1 (fr)	2002-12-28	Antagonistes de récepteurs de vitronectine.
BR9508178A (pt)	1997-11-18	Antagonistas de receptor de vitronectina
BR9612327A (pt)	1999-07-13	Antagonistas receptores de vitronectina
BR9612378A (pt)	1999-07-13	Antagonistas receptores de vitronectina
TR199801594A3 (tr)	1999-03-22	CCR-3 reseptör antagonistleri.
BR9612381A (pt)	1999-07-13	Antagonistas receptores vitronectina
BR9709952A (pt)	1999-08-10	Antagonistas de receptor de il-8
NO986109D0 (no)	1998-12-23	IL-8 reseptor-antagonister
DE69812096D1 (de)	2003-04-17	Neuropeptid y rezeptorantagonisten
NO972016D0 (no)	1997-04-30	Indolyl-Y-reseptorantagonister
NO993350D0 (no)	1999-07-07	Vitronectin-reseptor-antagonister
EP0810994A4 (fr)	1998-05-06	Antagonistes des recepteurs de fibrinogene
EP0885205A4 (fr)	2002-11-27	Antagonistes des recepteurs de fibrinogenes
BR9711140A (pt)	1999-08-17	Antagonistas receptores de il-8
TR199600359A2 (tr)	1996-11-21	Adezyon reseptörü antagonistleri.
ID24726A (id)	2000-08-03	Antagonis-antagonis reseptor trombin
DK0906294T3 (da)	2003-05-05	Benzoxazinon-dopamin D4-receptor-antagonister
NO20004503L (no)	2000-10-10	Vitronectin-reseptor-antagonister
EP0684823A4 (fr)	1997-07-09	Antagonistes des recepteurs de fibrinogene.
NO20001407D0 (no)	2000-03-17	Vitronectin-reseptor-antagonister
NO20001514D0 (no)	2000-03-23	Vitronectin-reseptor-antagonist
NO20001515D0 (no)	2000-03-23	Vitronektin reseptor-antagonist
DZ2322A1 (fr)	2002-12-28	Antagonistes de récepteurs de vitronectine.
TR199501389A2 (tr)	1996-07-21	Adesyon reseptörü antagonistleri (karsitlari).
BR9507220A (pt)	1997-09-09	Antagonistas de receptores de endotelina